246 related articles for article (PubMed ID: 10027117)
1. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.
Grubb BP; Karas BJ
J Interv Card Electrophysiol; 1998 Dec; 2(4):325-32. PubMed ID: 10027117
[No Abstract] [Full Text] [Related]
2. Clinical practice. Neurocardiogenic syncope.
Grubb BP
N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
[No Abstract] [Full Text] [Related]
3. Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope.
Quan KJ; Carlson MD; Thames MD
Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):764-74. PubMed ID: 9080508
[TBL] [Abstract][Full Text] [Related]
4. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
Lazarus JC; Mauro VF
Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
[TBL] [Abstract][Full Text] [Related]
5. The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing.
Grubb BP; Kosinski DJ; Boehm K; Kip K
Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2205-12. PubMed ID: 9309745
[TBL] [Abstract][Full Text] [Related]
6. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
Massin M
Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
[TBL] [Abstract][Full Text] [Related]
7. Neurocardiogenic syncope: latest pharmacological therapies.
Chen LY; Shen WK
Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and management of neurocardiogenic syncope.
Nair N; Padder FA; Kantharia BK
Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677
[TBL] [Abstract][Full Text] [Related]
9. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
[TBL] [Abstract][Full Text] [Related]
10. The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope -- a preliminary report.
Lenk M; Alehan D; Ozme S; Celiker A; Ozer S
Eur J Pediatr; 1997 Oct; 156(10):747-50. PubMed ID: 9365060
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for fainting spells.
Harv Heart Lett; 1999 Sep; 10(1):3. PubMed ID: 10445969
[No Abstract] [Full Text] [Related]
12. Medical therapy of neurocardiogenic syncope.
Cadman CS
Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
[TBL] [Abstract][Full Text] [Related]
13. Vasovagal syncope: an update on the latest pharmacological therapies.
Schleifer JW; Shen WK
Expert Opin Pharmacother; 2015 Mar; 16(4):501-13. PubMed ID: 25534874
[TBL] [Abstract][Full Text] [Related]
14. SSRIs for vasodepressor syncope?
Grubb BP
Postgrad Med; 2000 Nov; 108(6):29, 32. PubMed ID: 11098257
[No Abstract] [Full Text] [Related]
15. Role of the serotonergic system in the genesis of vasovagal syncope.
Alboni P; Bondanelli M; Dinelli M; Gruppillo P; Franceschetti P; Marchi P; degli Uberti EC
Europace; 2000 Apr; 2(2):172-80. PubMed ID: 11225944
[TBL] [Abstract][Full Text] [Related]
16. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
[TBL] [Abstract][Full Text] [Related]
17. A review of pathophysiology and therapy of patients with vasovagal syncope.
White CM; Tsikouris JP
Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
[TBL] [Abstract][Full Text] [Related]
18. Neurocardiogenic syncope and related disorders of orthostatic intolerance.
Grubb BP
Circulation; 2005 Jun; 111(22):2997-3006. PubMed ID: 15939833
[No Abstract] [Full Text] [Related]
19. Strategy for the management of vasovagal syncope.
Bloomfield DM
Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
